Skip to main content

Table 3 Association between metabolic syndromea and prostate cancer risk according to screening, age, ancestry and diabetes

From: Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada

Strata characteristics

N

ORb

95 % CI

DRE screened in the last five years

3202

  

 All cases

 

0.70

0.60-0.82

 Non aggressive cases

 

0.68

0.57-0.81

 Aggressive cases

 

0.75

0.60-0.95

Screened during the last two years

3387

0.62

0.50-0.78

Age at diagnosis (cases) / interview (controls)

   

 < 65 years

1892

0.60

0.47-0.76

 ≥ 65 years

1986

0.79

0.64-0.96

Ancestry

   

 Sub-Saharan

217

0.80

0.36-1.78

 Other (including European, Greater Middle East, Asiatic and Latino ancestries)

3650

0.70

0.60-0.82

Type 2 diabetes

   

 No

3340

0.80

0.67-0.96

 Yes

551

0.67

0.44-1.01

  1. aAccording to the definition of the Adult Treatment Panel III from the National Cholesterol Education Program
  2. bAdjusted for age, family history of prostate cancer, ancestry, prostate cancer screening 2 years earlier, and family income
  3. CI, Confidence interval; DRE, Digital rectal examination; OR, Odds ratio